Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric germ cell tumors

F J Rescorla1

  • 1J.W. Riley Hospital for Children, Indianapolis, Indiana 46202, USA. frescorl@iupui.edu

Seminars in Surgical Oncology
|February 16, 1999
PubMed
Summary
This summary is machine-generated.

Childhood germ cell tumors, though rare, are treatable with advances in platinum-based chemotherapy. Surgical resection and chemotherapy significantly improve survival rates for both gonadal and extragonadal tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for acute chest syndrome in children with sickle cell disease undergoing abdominal surgery.

Journal of pediatric surgery·2004
Same author

Long-term analysis of children with esophageal atresia and tracheoesophageal fistula.

Journal of pediatric surgery·2003
Same author

Portal venous air: the poor prognosis persists.

Journal of pediatric surgery·2001
Same author

The utility of lung biopsy in recipients of stem cell transplantation.

Journal of pediatric surgery·2001
Same author

Pectus excavatum repair: experience with standard and minimal invasive techniques.

Journal of pediatric surgery·2001
Same author

Gastroschisis: a plea for risk categorization.

Journal of pediatric surgery·2001
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Childhood germ cell tumors are rare, often presenting as large gonadal or extragonadal masses.
  • Extragonadal tumors are more common in younger children, while gonadal tumors are prevalent in older children and adolescents.

Purpose of the Study:

  • To review the management and outcomes of pediatric germ cell tumors.
  • To highlight the impact of platinum-based chemotherapy on survival rates.

Main Methods:

  • Review of treatment strategies including surgical resection, chemotherapy, and neoadjuvant approaches.
  • Analysis of survival data based on tumor site (gonadal vs. extragonadal) and stage.

Main Results:

  • Survival rates for pediatric germ cell tumors have improved significantly over the last two decades.

Related Experiment Videos

  • Stage I/II gonadal tumors have near 100% survival; Stage III/IV gonadal tumors have ~95% survival.
  • Extragonadal tumors show ~90% survival for Stages I/II and ~75% for Stages III/IV.

    • Conclusions:

    • Surgical excision and platinum-based chemotherapy are effective in treating pediatric germ cell tumors.
    • Improved outcomes are observed for both localized and advanced disease, with high survival rates achieved.
    • Continued advancements in chemotherapy regimens contribute to the favorable prognosis for these rare pediatric cancers.